Ocular Therapeutix (OCUL) Financials: Revenue & Earnings
OCUL$7.13+0.41 +6.06%
$1.57B
Market Cap
-4.56
P/E
356.38
Forward P/E
49
Score
Ocular Therapeutix (OCUL) Financials: Revenue & Earnings
OCUL price $7.13 +0.41 +6.06%
- Ticker
- OCUL
- Price
- $7.13
- Change
- +0.41 +6.06%
- Market cap ?
- $1.57B
- P/E ?
- -4.56
- Forward P/E ?
- 356.38
- Dividend yield ?
- 0.00%
- Beta ?
- 0.99
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 49
- Value
- 58
- Quality
- 34
- Growth
- 54
Stocklytics score rationale: value 58, quality 34, growth 54.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1887000 | 1923000 | 1990000 | 4227000 | 17403000 | 43522000 | 51494000 | 58443000 | 63723000 | 51823000 |
Ocular Therapeutix, Inc. is a biopharmaceutical company specializing in the creation, advancement, and commercialization of ophthalmic treatments. Their innovative approach leverages a proprietary bioresorbable hydrogel technology to address a range of eye diseases and conditions. The company currently offers two key products: ReSure Sealant, an ophthalmic device designed to prevent fluid leakage from corneal…
Fair value
OCUL fair value $2.24. Price $7.13. Price is 218% above fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 10.93M. Growth 1.83%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.76% (beta 1.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 219.62M. Net debt -657.28M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-03 | — | -0.36 | — | 14.27M |
| 2026-08-03 | -0.35 | -0.40 | 13.47M | 13.20M |
| 2026-05-05 | -0.41 | -0.32 | 10.79M | 12.72M |
| 2026-02-05 | -0.29 | -0.33 | 13.25M | 16.13M |
| 2025-11-04 | -0.37 | -0.39 | 14.54M | 16.14M |
| 2025-08-05 | -0.39 | -0.35 | 13.46M | 14.57M |
| 2025-05-05 | -0.37 | -0.29 | 10.63M | 13.10M |
| 2025-03-03 | -0.29 | -0.24 | 17.08M | 17.11M |
| 2024-11-14 | -0.26 | -0.23 | 15.43M | 16.89M |
| 2024-08-07 | -0.24 | -0.22 | 16.44M | 15.82M |
| 2024-05-07 | -0.49 | -0.18 | 14.77M | 15.36M |
| 2024-03-11 | -0.28 | -0.28 | 14.80M | 15.71M |
| 2023-11-07 | -0.51 | -0.29 | 15.08M | 15.23M |
| 2023-08-07 | -0.27 | -0.29 | 15.19M | 14.65M |
| 2023-05-08 | -0.31 | -0.27 | 13.37M | 14.10M |
| 2023-03-06 | -0.24 | -0.25 | 14.08M | 13.53M |
| 2022-11-07 | -0.30 | -0.23 | 11.96M | 14.27M |
| 2022-08-08 | -0.28 | -0.23 | 12.27M | 14.25M |
| 2022-05-09 | -0.22 | -0.25 | 13.19M | 13.96M |
| 2022-02-28 | -0.23 | -0.23 | 12.31M | 13.94M |
| 2021-11-08 | -0.23 | -0.26 | 12.15M | 13.88M |
| 2021-08-09 | -0.25 | -0.20 | 11.72M | 11.72M |
| 2021-05-05 | -0.24 | -0.20 | 7.34M | 9.76M |
| 2021-03-11 | -0.23 | -0.18 | 7.35M | — |
| 2020-11-05 | -0.17 | -0.23 | 5.88M | 1.94M |
| 2020-08-07 | -0.34 | -0.32 | 1.57M | 1.27M |
| 2020-05-08 | -0.41 | -0.40 | 2.61M | 2.35M |
| 2020-03-12 | -0.47 | -0.42 | 2.26M | 1.92M |
| 2019-11-12 | -0.45 | -0.46 | 829.00K | 974.08K |
| 2019-08-07 | -0.57 | -0.42 | 650.00K | 547.37K |
| 2019-05-10 | -0.45 | -0.42 | 492.00K | 504.00K |
| 2019-03-07 | -0.42 | -0.37 | 504.00K | 456.00K |
| 2018-11-07 | -0.38 | -0.36 | 498.00K | 498.00K |
| 2018-08-07 | -0.37 | -0.37 | 648.00K | 648.00K |
| 2018-05-08 | -0.40 | -0.39 | 340.00K | 323.00K |
| 2018-03-08 | -0.44 | -0.58 | 487.00K | 575.55K |
| 2017-11-07 | -0.54 | -0.54 | 523.00K | 513.31K |
| 2017-08-08 | -0.64 | -0.59 | 438.00K | 383.25K |
| 2017-05-05 | -0.58 | -0.48 | 475.00K | 393.10K |
| 2017-03-10 | -0.45 | -0.47 | 511.00K | 442.21K |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-08 | Anderman Todd | Sell | 11.98K | $7.29 | 87.36K |
| 2026-10-02 | Kaiser Peter | Sell | 9.99K | $7.05 | 70.43K |
| 2026-10-02 | Heier Jeffrey S. | Sell | 10.87K | $7.05 | 76.63K |
| 2026-08-31 | Notman Donald | Sell | 1.10K | $10.24 | 11.25K |
| 2026-08-25 | Dugel Pravin | Buy | 50.09K | — | — |
| 2026-08-25 | Dugel Pravin | Sell | 50.09K | — | — |
| 2026-08-24 | Kaiser Peter | Sell | 3.04K | $10.77 | 32.69K |
| 2026-08-24 | Nayak Sanjay | Sell | 1.90K | $10.78 | 20.45K |
| 2026-08-24 | Heier Jeffrey S. | Sell | 3.30K | $10.78 | 35.53K |
| 2026-08-24 | Dugel Pravin | Sell | 21.65K | $10.77 | 233.16K |
| 2026-06-16 | Dugel Pravin | Sell | 50.09K | — | — |
| 2026-06-16 | Dugel Pravin | Buy | 50.09K | — | — |
| 2026-06-10 | Warden Charles M | Buy | 14.00K | — | — |
| 2026-06-10 | Warden Charles M | Buy | 44.00K | $8.74 | 384.56K |
| 2026-06-10 | Graves Adrienne L | Buy | 14.00K | — | — |
| 2026-06-10 | Graves Adrienne L | Buy | 44.00K | $8.74 | 384.56K |
| 2026-06-10 | Robins Jason Shand | Buy | 15.44K | — | — |
| 2026-06-10 | Robins Jason Shand | Buy | 14.02K | $8.74 | 122.57K |
| 2026-06-10 | Hong Seung Suh | Buy | 14.00K | — | — |
| 2026-06-10 | Hong Seung Suh | Buy | 44.00K | $8.74 | 384.56K |
| 2026-06-10 | LINDSTROM RICHARD L MD | Buy | 14.00K | — | — |
| 2026-06-10 | LINDSTROM RICHARD L MD | Buy | 44.00K | $8.74 | 384.56K |
| 2026-06-10 | RAINES MERILEE | Buy | 14.00K | — | — |
| 2026-06-10 | RAINES MERILEE | Buy | 44.00K | $8.74 | 384.56K |
| 2026-06-10 | Williams Leslie J. | Buy | 14.00K | — | — |
| 2026-06-10 | Williams Leslie J. | Buy | 44.00K | $8.74 | 384.56K |
| 2026-06-03 | Waheed Nadia | Sell | 14.83K | $8.27 | 122.63K |
| 2026-05-28 | Dugel Pravin | Buy | 394.70K | — | — |
| 2026-05-28 | Dugel Pravin | Sell | 394.70K | — | — |
| 2026-05-26 | Dugel Pravin | Sell | 21.16K | $8.20 | 173.48K |
| 2026-05-26 | Kaiser Peter | Sell | 2.97K | $8.20 | 24.33K |
| 2026-05-26 | Heier Jeffrey S. | Sell | 3.02K | $8.20 | 24.75K |
| 2026-05-26 | Nayak Sanjay | Sell | 1.86K | $8.20 | 15.24K |
| 2026-04-09 | Dugel Pravin | Sell | 394.70K | — | — |
| 2026-04-09 | Dugel Pravin | Buy | 394.70K | — | — |
| 2026-02-23 | Dugel Pravin | Sell | 20.06K | $8.28 | 166.06K |
| 2026-02-23 | Kaiser Peter | Sell | 2.81K | $8.28 | 23.27K |
| 2026-02-23 | Heier Jeffrey S. | Sell | 3.06K | $8.28 | 25.31K |
| 2026-02-23 | Nayak Sanjay | Sell | 1.76K | $8.28 | 14.56K |
| 2026-02-20 | Waheed Nadia | Sell | 3.51K | $7.74 | 27.17K |
| 2026-02-20 | LINDSTROM RICHARD L MD | Buy | 60.23K | $7.66 | 461.35K |
| 2026-02-12 | Notman Donald | Sell | 11.45K | $9.04 | 103.47K |
| 2026-02-12 | Nayak Sanjay | Sell | 10.35K | $9.04 | 93.55K |
| 2026-02-12 | Dugel Pravin | Sell | 124.88K | $9.04 | 1.13M |
| 2026-02-12 | Waheed Nadia | Sell | 7.86K | $9.04 | 71.08K |
| 2026-02-04 | Notman Donald | Sell | 6.04K | $8.54 | 51.54K |
| 2026-02-02 | Notman Donald | Sell | 5.46K | $9.14 | 49.86K |
| 2026-01-21 | Robinson David Wayne | Buy | 416.00K | $11.42 | 4.75M |
| 2026-01-21 | Robinson David Wayne | Buy | 136.00K | — | — |
| 2026-01-21 | Robinson David Wayne | Other | 0 | — | — |
| 2026-01-20 | Robins Jason Shand | Buy | 33.00K | $11.45 | 377.85K |
| 2026-01-20 | Robins Jason Shand | Other | 0 | — | — |
| 2026-01-20 | Robins Jason Shand | Other | 68.19K | $11.82 | 806.06K |
| 2026-01-20 | Robins Jason Shand | Other | 110.60K | $8.12 | 898.07K |
| 2026-01-02 | Anderman Todd | Buy | 197.65K | $11.82 | 2.34M |
| 2026-01-02 | Anderman Todd | Buy | 64.90K | — | — |
| 2026-01-02 | Meyers Steve Lawrence | Buy | 64.90K | — | — |
| 2026-01-02 | Meyers Steve Lawrence | Buy | 197.65K | $11.82 | 2.34M |
| 2026-01-02 | Nayak Sanjay | Buy | 64.90K | — | — |
| 2026-01-02 | Nayak Sanjay | Buy | 197.65K | $11.82 | 2.34M |
| 2026-01-02 | Kaiser Peter | Buy | 79.11K | — | — |
| 2026-01-02 | Kaiser Peter | Buy | 240.93K | $11.82 | 2.85M |
| 2026-01-02 | Saroj Namrata | Buy | 79.11K | — | — |
| 2026-01-02 | Saroj Namrata | Buy | 240.93K | $11.82 | 2.85M |
| 2026-01-02 | Waheed Nadia | Buy | 79.11K | — | — |
| 2026-01-02 | Waheed Nadia | Buy | 240.93K | $11.82 | 2.85M |
| 2026-01-02 | Heier Jeffrey S. | Buy | 79.11K | — | — |
| 2026-01-02 | Heier Jeffrey S. | Buy | 240.93K | $11.82 | 2.85M |
| 2026-01-02 | Notman Donald | Buy | 79.11K | — | — |
| 2026-01-02 | Notman Donald | Buy | 240.93K | $11.82 | 2.85M |
| 2025-11-26 | Dugel Pravin | Buy | 49.75K | — | — |
| 2025-11-26 | Dugel Pravin | Sell | 49.75K | — | — |
| 2025-11-24 | Nayak Sanjay | Sell | 1.88K | $12.04 | 22.61K |
| 2025-11-24 | Dugel Pravin | Sell | 19.53K | $12.04 | 235.14K |
| 2025-11-24 | Kaiser Peter | Sell | 3.01K | $12.02 | 36.14K |
| 2025-11-24 | Heier Jeffrey S. | Sell | 3.47K | $12.04 | 41.77K |
| 2025-11-05 | Saroj Namrata | Sell | 25.86K | $10.74 | 277.79K |
| 2025-10-08 | Anderman Todd | Sell | 11.13K | $12.34 | 137.37K |
| 2025-10-02 | Kaiser Peter | Sell | 9.65K | $11.03 | 106.47K |
| 2025-10-02 | Heier Jeffrey S. | Sell | 10.50K | $11.04 | 115.94K |
| 2025-09-09 | Dugel Pravin | Sell | 49.75K | — | — |
| 2025-09-09 | Dugel Pravin | Buy | 49.75K | — | — |
| 2025-09-02 | Notman Donald | Sell | 1.07K | $12.43 | 13.25K |
| 2025-08-25 | Kaiser Peter | Sell | 3.01K | $12.04 | 36.25K |
| 2025-08-25 | Nayak Sanjay | Sell | 1.89K | $12.04 | 22.70K |
| 2025-08-25 | Heier Jeffrey S. | Sell | 3.06K | $12.04 | 36.88K |
| 2025-08-25 | Dugel Pravin | Sell | 21.49K | $12.04 | 258.79K |
| 2025-08-12 | Waheed Nadia | Buy | 40.36K | — | — |
| 2025-08-12 | Waheed Nadia | Buy | 122.92K | $12.48 | 1.53M |
| 2025-08-11 | Dugel Pravin | Buy | 250.36K | — | — |
| 2025-06-12 | Dugel Pravin | Sell | 50.03K | — | — |
| 2025-06-11 | Meyers Steve Lawrence | Other | 0 | — | — |
| 2025-06-11 | Meyers Steve Lawrence | Other | 45.00K | $5.22 | 234.90K |
| 2025-06-11 | Meyers Steve Lawrence | Other | 222.00K | $7.44 | 1.65M |
| 2025-06-11 | Meyers Steve Lawrence | Other | 145.00K | $5.18 | 751.10K |
| 2025-06-11 | Meyers Steve Lawrence | Other | 100.00K | $3.88 | 388.00K |
| 2025-06-11 | Saroj Namrata | Other | 0 | — | — |
| 2025-06-11 | Saroj Namrata | Other | 100.00K | $9.95 | 995.00K |
| 2025-06-11 | Saroj Namrata | Other | 316.00K | $10.27 | 3.25M |
| 2025-06-11 | Dugel Pravin | Buy | 2.75M | $7.44 | 20.46M |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 277, holders -11 vs prior quarter. Ownership 93.14%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| FMR LLC | 32.84M | 190.28K | +0.58% | 322.53M |
| DEEP TRACK CAPITAL, LP | 19.69M | 0 | 0.00% | 193.32M |
| BLACKROCK, INC. | 19.38M | 3.24M | +20.11% | 190.28M |
| AVORO CAPITAL ADVISORS LLC | 12.54M | 225.00K | +1.83% | 123.14M |
| SUMMER ROAD LLC | 12.21M | 328.47K | +2.76% | 119.89M |
| VENROCK ADVISER, LLC | 10.35M | 0 | 0.00% | 101.61M |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.83M | 113.56K | +1.30% | 86.74M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 7.62M | 1.73M | +29.27% | 74.86M |
| LOGOS GLOBAL MANAGEMENT LP | 5.30M | 1.45M | +37.66% | 52.05M |
| STATE STREET CORP | 5.23M | 524.86K | +11.15% | 51.39M |
| GEODE CAPITAL MANAGEMENT, LLC | 5.02M | 491.91K | +10.86% | 49.32M |
| POINT72 ASSET MANAGEMENT, L.P. | 3.29M | -2.24M | -40.52% | 32.33M |
| DIMENSIONAL FUND ADVISORS LP | 2.78M | 2.13M | +328.37% | 27.33M |
| DELTEC ASSET MANAGEMENT LLC | 2.48M | 135.58K | +5.79% | 24.32M |
| BALYASNY ASSET MANAGEMENT L.P. | 2.27M | -421.92K | -15.67% | 22.30M |
| OCTAGON CAPITAL ADVISORS LP | 2.08M | -1.09M | -34.47% | 20.38M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.97M | 378.46K | +23.73% | 19.38M |
| NORTHERN TRUST CORP | 1.80M | 273.80K | +17.95% | 17.67M |
| GOLDMAN SACHS GROUP INC | 1.76M | 651.39K | +58.66% | 17.30M |
| NUVEEN, LLC | 1.70M | 1.29M | +312.88% | 16.67M |
| WOODLINE PARTNERS LP | 1.67M | 0 | 0.00% | 16.38M |
| TCG CROSSOVER MANAGEMENT, LLC | 1.65M | 0 | 0.00% | 16.18M |
| UBS GROUP AG | 1.55M | 30.37K | +2.00% | 15.23M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.55M | 1.55M | New | 15.22M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 1.53M | 1.53M | New | 15.06M |
Earnings and financials
Ocular Therapeutix, Inc. (OCUL) trades at $7.13, with a market cap of $1.57B and a trailing P/E of -4.56. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1887000 | 1923000 | 1990000 | 4227000 | 17403000 | 43522000 | 51494000 | 58443000 | 63723000 | 51823000 |
Insights · Dividends · Forecast · Financials · Learn